Chemoinformaics analysis of Cyclocopacamphan-12-al
| Molecular Weight | 218.34 | nRot | 2 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 14 |
| Exact Molecular Weight | 218.167 | nRing | 5 |
| Solubility: LogS | -3.304 | nHRing | 0 |
| Solubility: LogP | 2.453 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 6 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 40.5214 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.651 |
| Synth | 6.242 |
| Natural Product Likeliness | 2.99 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.722 |
| MDCK | 0.0000899 |
| BBB | 0.917 |
| PPB | 0.585219 |
| VDSS | 4.038 |
| FU | 0.286069 |
| CYP1A2-inh | 0.124 |
| CYP1A2-sub | 0.705 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.935 |
| CYP2c9-inh | 0.057 |
| CYP2c9-sub | 0.163 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.607 |
| CYP3a4-inh | 0.285 |
| CYP3a4-sub | 0.573 |
| CL | 20.571 |
| T12 | 0.151 |
| hERG | 0.025 |
| Ames | 0.035 |
| ROA | 0.681 |
| SkinSen | 0.341 |
| Carcinogencity | 0.065 |
| EI | 0.051 |
| Respiratory | 0.878 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.845098 |